Scientific Programming - PDF document

1 Scientific Programming PODIUM PRESENTA
Scientific Programming PODIUM PRESENTATIONS: Scientific Session 1 Is CT Scientific Session 2 Distinguished Moderator #1 AdrenalAssociation of the Affordable Care Act with Access to HighestVolume Centers for Patients with Thyroid CancerJacques Greenberg, Weill Cornell Medical College / New York Scientific Session 3 Identification of novel lipid metabolic biomarkers associated with poor adrenocortical carcinoma prognosis using integrated bioinformatics.Chitra Subramanian, University of MichiganMast Cell Immunogenomic Computational Deconvolution of Adrenocortical Carcinoma Tumor MicroenvironmentJordan Baechle, Meharry Medical CollegeSubcutaneous Transplantation of Human Thyroid Cells into a PreVascularized Cell Pouch™ Device in a Murine Model: Evidence of Viability and Function for Thyroid Cell TherapySam Wiseman, St. Paul's Hospital & University of British ColumbiaExpression of Cancer Stem Cell Markers in Tall Cell Variant Papillary Thyroid Cancer Identifies a Molecular Profile Predictive of Recurrence in Classic Papillary Thyroid CancerAnna Beck, University of Iowa Hospitals and ClinicsGlycolytic Inhibition with 3Bromopyruvate Suppresses Tumor Growth and Improves Survival in a Murine Model of Anaplastic Thyroid CancerBixiao Zhao, Brigham and Women's HospitalInhibition of autophagy mitigates cell migration and invasion in thyroid cancerTammy Holm, University of Cincinnati College of Medicine Scientific Session 4 Perspectives on Virtual InterviewsA Followup Study of the Comprehensive Endocrine

2 Surgery Fellowship Interview Processlai
Surgery Fellowship Interview Processlaina Geary, Boston University Medical CenterThe Glass Podium: Gender Representation within the American Association of Endocrine Surgeons (AAES) from 20102019Sean Wrenn, Rush University Medical Center Optimal SurgeonVolume Threshold for Neck Dissections in the Setting of Primary Thyroid MalignanciesRahul Sharma,Columbia University Irving Medical CenterAmbient Particulate Matter Air Pollution Increases Risk of Papillary Thyroid Cancer: a CaseControl StudyShkala Karzai, Johns Hopkins University School of Medicine Scientific Session 5 Distinguished Moderator #2 secondary/tertiary paraParathyroidectomy versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Patients Receiving Dialysis. A Propensity Score Matched Analysis.Nishtha Sharma, Texas Tech Health Sciences Center Paul L Foster School of Medicine Prevalence and Risk Factors for Tertiary Hyperparathyroidism in Kidney Transplant RecipientsWhitney Sutton, Johns Hopkins University School of MedicineData to Inform Counseling on Parathyroidectomy for Secondary Hyperparathyroidism of Renal OrigRebecca WilliamsKarnesky, University of New Mexico Scientific Session 6 Screening for Primary Aldosteronism in the Hypertensive Obstructive Sleep Apnea Population is CostSavingKathryn ChomskyHiggins, University of California, San FranciscoCost Analysis of Reflexive vs. Selective Molecular Testing for Indeterminate Thyroid NodulesQ. Lina Hu, University of California, Los AngelesThyroid lobectomy as a costeffective

3 approach in lowrisk papillary thyroid ca
approach in lowrisk papillary thyroid cancer versus Active SurveillanceAbdallah Attia, Tulane UniversityA costutility analysis of fluorocholinePET imaging for primary hyperparathyroidism in the United StatesAva Yap, University of California, San Francisco Scientific Session 7 Stones left unturned: missed opportunities to diagnose primary hyperparathyroidism in patients with nephrolithiasisMichael Lui, New York University School of MedicineIs a Routine 24hour Urine Calcium Measurement Essential During the Evaluation of Primary Hyperparathyroidism?Shimena Li, UPMCLONGTERM FOLLOWUP CONFIRMS UTILITY OF 18FFLUOROCHOLINE PET LOCALIZATION FOR PRIMARY HYPERPARATHYROIDISMClaire Graves, University of California DavisParathyroidectomy for nephrolithiasis in primary hyperparathyroidism: beneficial but not a panacea?SiuYuan Huang, Kaiser Permanente Los Angeles Medical CenterRecurrence after Successful Parathyroidectomy Who Should We Worry About?Aditya Shirali, University of Texas MD Anderson Cancer Center Scientific Session 8 Distinguished Moderator #3 thyroidA Prospective Randomized Controlled Trial on the Efficacy and Safety of Prophylactic Central Compartment Lymph Node Dissection in Papillary Thyroid Carcinoma.Jonghyuk Ahn, Seoul National University Hostpital Rate of Occult Malignancy May Be A Deterrent to RadiofrequencyAblation for Benign Thyroid DiseaseJina Kim, Inova Schar Cancer InstituteAge determines treatment for T2N0M0 papillary thyroid cancerErin MacKinney, NorthShore University HealthSystemRadioactiv

4 e iodine does not improve overall surviv
e iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cmSimon Holoubek, Augusta UniversityIntraoperative translaryngeal ultrasonography (LUSG) of the vocal cord is a novel method of confirming the recurrent laryngeal nerve (RLN) integrity during thyroid and neck surgeryMan Him Matrix Fung, Queen Mary Hospital, University of Hong KongMedullary Thyroid Cancer: What is the optimal management of the lateral neck in a node negative patient at index operation?Thomas Szabo Yamashita, Mayo Clinic QUICK SHOT PRESENTATIONS: Quick Shot Poster Session 1 Longterm Voice Changes After Thyroidectomy: Results from a Validated SurveyChun Li, Beth Israel Deaconess Medical CenterOut of Pocket Costs for Commercial Patients Undergoing ThyroidectomyFeibiZheng, Houston Methodist HospitalPostthyroidectomy hypocalcemia: is a routine preferable over a selective supplementation?Luca Sessa, Fondazione Policlinico Universitario Agostino Gemelli IRCCSImpact of a Systemwide Adrenal Incidentaloma Quality Improvement Initiative a Prospective StudyAlison Woods, Johns Hopkins University School of MedicineGeneration of an organoid model of adrenocortical carcinomaHemamylammal SugavanamSivakumar, Ohio State UniversityA prospective study comparing the midline and lateral translaryngeal ultrasonography approaches in the assessment of vocal cords before and after thyroid and neck surgeriesMan Him Matrix Fung, Queen Mary Hospital, University of Hong KongEnhancing riskstra

5 tification of indeterminate thyroid nodu
tification of indeterminate thyroid nodules using Artificial Neural Networkenabled image analysis.Kelvin Memeh, The University of Chicago MedicinePerception of Risk and Decision on Treatment in the Management of Differentiated Thyroid CancerMax Schumm, UCLA Quick Shot Poster Session 2 Molecular fluorescenceguided imaging of papillary thyroid cancer nodal metastasis using a fluorescent tracer targeting MET can be used to detect lymph node metastasisMadelon Metman, University Medical Center GroningenSurgical treatment of metastatic disease in the adrenal gland; how to inform the patient?Madelon Metman, University Medical Center GroningenPreOperative Blockade for Pheochromocytoma: Is it Time to Retire Phenoxybenzamine?Jordan George, University of Alabama at BirminghamSurgical Treatment of Hyperthyroidism Can Be Performed Safely Before a Euthryoid State is AchievedJessica Fazendin, University of Alabama at BirminghamScreening for Primary Hyperaldosteronism is Underutilized in Patients with Obstructive Sleep ApneaPatriciaConroy, University of California, San FranciscoRNASequencing Identifies Unique Molecular Features of Duodenal Neuroendocrine TumorsCatherine Tran, University of Iowa Carver College of MedicineCirculating microRNA signatures in primary hyperparathyroidismHeather Wachtel, University of PennsylvaniaEvaluating impact of near Infrared autofluorescence detection for identifying parathyroid glands during parathyroidectomies a randomized singlecenter clinical trial.Giju Thomas, Vanderbilt Universit